small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (382)
  • Capabilities (79)
  • Experience (112)
  • Insights & News (2,050)
  • Other Results (43)

Professionals 382 results

Linda Coberly
Linda Coberly
Partner
  • Chicago
Email
+1 312-558-8768
vCard

Partner

  • Chicago
Michael Kimberly
Michael Kimberly
Partner
  • Washington, DC
Email
+1 202-282-5096
vCard

Partner

  • Washington, DC
Scott Glauberman
Scott Glauberman
Partner
  • Chicago
Email
+1 312-558-8103
vCard

Partner

  • Chicago
View All Professionals

Capabilities 79 results

Practice Area

Appellate & Critical Motions

Our nationally recognized Appellate & Critical Motions (ACM) Practice delivers sophisticated legal advocacy and analysis before trial, at trial, and on appeal. From state trial courts to the U.S. Supreme Court, our ACM attorneys identify, preserve, and present the critical legal issues that can make the difference between winning and losing....Read more

Practice Area

Litigation/Trials

Trial skills matter—even in a world where few disputes ever see the inside of a courtroom. Winston has built a reputation as a trial lawyers’ firm, featuring seasoned litigators who leverage extensive courtroom experience to meet our clients’ business and legal objectives. Our long history of taking cases to trial—and winning—provides our clients with tremendous settlement leverage with their adversaries, as well as a substantial likelihood of a favorable resolution if, and when, they go to trial....Read more

Practice Area

Corporate Governance

Our attorneys have extensive experience counseling U.S. and multinational public companies across a range of industries in all aspects of corporate governance, securities, and compliance matters. We advise public companies, boards of directors and their committees, and senior executives on the corporate governance and compliance matters that public companies and their leadership confront—from board structuring and succession planning to shareholder activism and SEC regulation. Drawing on our experience as seasoned counselors, we keep clients abreast of evolving trends and best practices to proactively manage any governance or compliance issues. We have assembled one of the most experienced teams of any law firm in the country that’s counseling public companies....Read more

Experience 112 results

Experience

|

April 2, 2026

Business Combination and Secured Financing of Keo World and Maha Capital AB

Served as legal counsel to KEO World, Inc., a Miami-based fintech platform specializing in embedded credit and B2B digital payments, in connection with its business combination with Maha Capital AB, a publicly listed investment company on Nasdaq Stockholm. The transaction, which closed on April 2, 2026, was structured as a reverse triangular merger through which KEO World became a wholly owned subsidiary of Maha, with KEO World's parent entity receiving approximately 141 million newly issued Maha shares and nearly 49.2 million earn-out warrants as consideration. In connection with the closing, Maha also executed two directed capital raises totaling USD 27 million at SEK 16 per share and announced a planned third raise of USD 8 million ahead of a contemplated dual listing on a U.S. national securities exchange. Based on publicly available disclosures, the combined transaction has been valued at approximately USD 680 million....Read more

Experience

|

March 16, 2026

Winston & Strawn Advises D. Boral Capital on $120 Million IPO of Pono Capital Four, Inc.

Winston & Strawn LLP served as counsel to D. Boral Capital LLC in connection with the $120 million initial public offering of Pono Capital Four, Inc.. The offering was led by D. Boral Capital LLC as sole book-running manager and consisted of 12,000,000 units priced at $10.00 per unit....Read more

Experience

|

March 6, 2026

Transition Evergreen & Zencap Agreement: Winston Advises Transition Evergreen on Its Restructuring

Transition Evergreen, a company listed on Euronext Paris and dedicated to ecological transition and carbon-footprint reduction, has completed the first phase of its financial restructuring by carrying out, on February 26 and 27, 2026, the operations set out in a settlement agreement concluded with its main creditor, a private debt fund managed by Zencap Asset Management (“Zencap”)....Read more
View All Experience

Insights & News 2,050 results

In the Media

|

May 11, 2026

|

1 Min Read

Ben Smolij Featured in Bloomberg Law’s Texas Brief Discussing IPO Readiness and Capital Markets Trends

Winston & Strawn partner Ben Smolij was featured in a Q&A for Bloomberg Law’s Texas Brief, where he shared insights on IPO readiness, evolving policy dynamics, and the future of capital markets in Texas....Read more

Recognitions

|

May 8, 2026

|

Less Than 1 Min Read

Winston Lawyers Featured on the 2026 Lawdragon 500 Leading Global Cyber Lawyers List

Winston & Strawn lawyers have been named to the 2026 Lawdragon Leading Global Cyber Lawyers list. This guide “celebrates the lawyers who handle the most sensitive online threats, protecting valuable data—including digital assets—shaping compliance programs, and protecting against corporate espionage and national security threats in the cyber realm.”...Read more

Recognitions

|

May 1, 2026

|

Less Than 1 Min Read

Winston Lawyers Recognized in World Intellectual Property Review’s Leaders Directory 2026

Winston & Strawn lawyers have been recognized in World Intellectual Property Review’s (WIPR) Leaders Directory 2026....Read more
View All Insights & News

Other Results 43 results

Law Glossary

Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?

The FDA maintains a list of biosimilar drugs that have been approved in the USA. This list can be found here....Read more

Law Glossary

What Is the Purple Book?

Maintained by the FDA, the Purple Book lists biologic products and biosimilar products that FDA has licensed under the Public Health Service Act. In addition, the Purple Book identifies the date each biologic obtained FDA licensure and indicates whether any biosimilar is interchangeable with its associated reference product....Read more

Site Content

What Is Blockchain?

Blockchain is a technological system in which a digital list of records stored across a network. The network is a shared database comprised of a large number of computers. Blockchain is the primary technology for cryptocurrencies....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising